A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 ...

Pooling of patient samples is commonly used in immunoassays and molecular diagnostics to increase testing capacity while reducing reagent costs for the analysis of SARS-CoV-2 and other infectious ...

On June 16, the U.S. Food and Drug Administration (FDA) posted updates to their Molecular Diagnostic Templates for developers that intend their assay to be used for pooled patient samples or for ...

WASHINGTON — The Food and Drug Administration has given emergency approval to a new approach to coronavirus testing that combines test samples in batches instead of running them one by one, speeding ...

One of the problems faced by health officials today is the vast number of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as they can still transmit the virus.

On July 18, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for sample pooling of specimens when using the SARS-CoV-2 rRT-PCR diagnostic test from Quest ...